MicroRNA-376c inhibits cell proliferation and invasion in osteosarcoma by targeting to transforming growth factor-alpha

DNA and Cell Biology

Volumn 32, Issue 6, 2013, Pages 302-309

  Jin, Yi ^a   Peng, Dan ^a   Shen, Yi ^a   Xu, Min ^a   Liang, Ying ^b   Xiao, Bowen ^c   Lu, Jing ^d  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY OF FORESTRY AND TECHNOLOGY   (China)

^c CHANGSHA CENTRAL HOSPITAL   (China)

^d HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; MICRORNA 376C; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULE; ONCOGENE; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TUMOR INVASION;

3' UNTRANSLATED REGIONS; BINDING SITES; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; OSTEOSARCOMA; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 84878444876     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.1977     Document Type: Article

References (34)

1. Ambros, V. (2004). The functions of animal microRNAs. Nature 431, 350-355.
2. Asangani, I. A., Rasheed, S. A., Nikolova, D. A., Leupold, J. H., Colburn, N. H., Post, S., and Allgayer, H. (2008). MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27, 2128-2136.
3. Bielack, S. S., Marina, N., Ferrari, S., Helman, L. J., Smeland, S., Whelan, J. S., and Reaman, G. H. (2008). Osteosarcoma: the same old drugs or more? J Clin Oncol 26, 3102-3105.
4. Booth, B. W., and Smith, G. H. (2007). Roles of transforming growth factor-alpha in mammary development and disease. Growth Factors 25, 227-235.
5. Calin, G. A., and Croce, C. M. (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6, 857-866.
6. Chan, J. A., Krichevsky, A. M., and Kosik, K. S. (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65, 6029-6033.
7. Chou, A. J., Geller, D. S., and Gorlick, R. (2008). Therapy for osteosarcoma: where dowe go fromhere? PaediatrDrugs 10, 315-327.
8. Dalmay, T., and Edwards, D. R. (2006). MicroRNAs and the hallmarks of cancer. Oncogene 25, 6170-6175.
9. Duan, Z., Choy, E., Harmon, D., Liu, X., Susa, M., Mankin, H., and Hornicek, F. (2011). MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Mol Cancer Ther 10, 1337-1345.
10. Esquela-Kerscher, A., and Slack, F. J. (2006). Oncomirs-micro-RNAs with a role in cancer. Nat Rev Cancer 6, 259-269.
11. Fang, J. H., Zhou, H. C., Zeng, C., Yang, J., Liu, Y., Huang, X., Zhang, J. P., Guan, X. Y., and Zhuang, S. M. (2011). MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology 54, 1729-1740.
12. Filipowicz, W. (2005). RNAi: the nuts and bolts of the RISC machine. Cell 122, 17-20.
13. Fornari, F., Milazzo, M., Chieco, P., Negrini, M., Calin, G. A., Grazi, G. L., Pollutri, D., Croce, C. M., Bolondi, L., and Gramantieri, L. (2010). MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res 70, 5184-5193.
14. Gaziel-Sovran, A., Segura, M. F., Di Micco, R., Collins, M. K., Hanniford, D., Vega-Saenz, D. M. E., Rakus, J. F., Dankert, J. F., Shang, S., and Kerbel, R. S., et al. (2011). miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell 20, 104-118.
15. Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., and Goodall, G. J. (2008). The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10, 593-601.
16. Hsieh, M., and Conti, M. (2005). G-protein-coupled receptor signaling and the EGF network in endocrine systems. Trends Endocrinol Metab 16, 320-326.
17. Hwang, H. W., and Mendell, J. T. (2006). MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 94, 776-780.
18. Korpal, M., Lee, E. S., Hu, G., and Kang, Y. (2008). The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 283, 14910-14914.
19. Kumar, V., Bustin, S. A., and McKay, I. A. (1995). Transforming growth factor alpha. Cell Biol Int 19, 373-388.
20. Li, N., Fu, H., Tie, Y., Hu, Z., Kong, W., Wu, Y., and Zheng, X. (2009). miR-34a inhibits migration and invasion by downregulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett 275, 44-53.
21. Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., and Johnson, J. M. (2005). Microarray analysis shows that somemicroRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773.
22. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., and Ferrando, A. A., et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435, 834-838.
23. Mishra, P. J., and Merlino, G. (2009). MicroRNA reexpression as differentiation therapy in cancer. J Clin Invest 119, 2119-2123.
24. O'Day, K., and Gorlick, R. (2009). Novel therapeutic agents for osteosarcoma. Expert Rev Anticancer Ther 9, 511-523.
25. Oneyama, C., Morii, E., Okuzaki, D., Takahashi, Y., Ikeda, J., Wakabayashi, N., Akamatsu, H., Tsujimoto, M., Nishida, T., and Aozasa, K., et al. (2012). MicroRNA-mediated upregulation of integrin-linked kinase promotes Src-induced tumor progression. Oncogene 31, 1623-1635.
26. Park, S. M., Gaur, A. B., Lengyel, E., and Peter, M. E. (2008). The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22, 894-907.
27. Ryan, B. M., Robles, A. I., and Harris, C. C. (2010). Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10, 389-402.
28. Vivacqua, A., Lappano, R., De Marco, P., Sisci, D., Aquila, S., De Amicis, F., Fuqua, S. A., Ando, S., and Maggiolini, M. (2009). G protein-coupled receptor 30 expression is up-regulated by EGF and TGF alpha in estrogen receptor alpha-positive cancer cells. Mol Endocrinol 23, 1815-1826.
29. Wang, F. E., Zhang, C., Maminishkis, A., Dong, L., Zhi, C., Li, R., Zhao, J., Majerciak, V., Gaur, A. B., and Chen, S., et al. (2010). MicroRNA-204/211 alters epithelial physiology. Faseb J 24, 1552-1571.
30. Wang, P., Zou, F., Zhang, X., Li, H., Dulak, A., Tomko, R. J., Lazo, J. S., Wang, Z., Zhang, L., and Yu, J. (2009). microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res 69, 8157-8165.
31. Winter, J., Jung, S., Keller, S., Gregory, R. I., and Diederichs, S. (2009). Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11, 228-234.
32. Xu, Y., Zhao, F., Wang, Z., Song, Y., Luo, Y., Zhang, X., Jiang, L., Sun, Z., Miao, Z., and Xu, H. (2012). MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene 31, 1398-1407.
33. Yang, C. H., Yue, J., Pfeffer, S. R., Handorf, C. R., and Pfeffer, L. M. (2011). MicroRNA miR-21 regulates the metastatic behavior of B16 melanoma cells. J Biol Chem 286, 39172-39178.
34. Zehavi, L., Avraham, R., Barzilai, A., Bar-Ilan, D., Navon, R., Sidi, Y., Avni, D., and Leibowitz-Amit, R. (2012). Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. Mol Cancer 11, 44.